St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
Sci Immunol. 2021 Nov 26;6(65):eabe3981. doi: 10.1126/sciimmunol.abe3981.
Helios, a member of the Ikaros family of transcription factors, is predominantly expressed in developing thymocytes, activated T cells, and regulatory T cells (T). Studies in mice have emphasized its role in maintenance of T immunosuppressive functions by stabilizing Foxp3 expression and silencing the locus. However, its contribution to human immune homeostasis and the precise mechanisms by which Helios regulates other T cell subsets remain unresolved. Here, we investigated a patient with recurrent respiratory infections and hypogammaglobulinemia and identified a germline homozygous missense mutation in encoding Helios (p.Ile325Val). We found that Helios retains DNA binding and dimerization properties but loses interaction with several partners, including epigenetic remodelers. Whereas patient T showed increased IL-2 production, patient conventional T cells had decreased accessibility of the locus and consequently reduced IL-2 production. Reduced chromatin accessibility was not exclusive to the locus but involved a variety of genes associated with T cell activation. Single-cell RNA sequencing of peripheral blood mononuclear cells revealed gene expression signatures indicative of a shift toward a proinflammatory, effector-like status in patient CD8 T cells. Moreover, patient CD4 T cells exhibited a pronounced defect in proliferation with delayed expression of surface checkpoint inhibitors, suggesting an impaired onset of the T cell activation program. Collectively, we identified a previously uncharacterized, germline-encoded inborn error of immunity and uncovered a cell-specific defect in Helios-dependent epigenetic regulation. Binding of Helios with specific partners mediates this regulation, which is ultimately necessary for the transcriptional programs that enable T cell homeostasis in health and disease.
Helios 是 Ikaros 转录因子家族的成员,主要在发育中的胸腺细胞、活化的 T 细胞和调节性 T 细胞(T 细胞)中表达。小鼠研究强调了其通过稳定 Foxp3 表达和沉默 基因座来维持 T 细胞免疫抑制功能的作用。然而,Helios 对人类免疫稳态的贡献以及 Helios 调节其他 T 细胞亚群的确切机制仍未解决。在这里,我们研究了一位反复呼吸道感染和低丙种球蛋白血症患者,并在编码 Helios 的 基因中发现了纯合的无义突变(p.Ile325Val)。我们发现 Helios 保留了 DNA 结合和二聚化特性,但失去了与包括表观遗传重塑因子在内的几个伴侣的相互作用。虽然患者 T 细胞的 IL-2 产生增加,但患者常规 T 细胞的 基因座的可及性降低,因此 IL-2 的产生减少。染色质可及性的降低不仅限于 基因座,还涉及与 T 细胞激活相关的各种基因。外周血单核细胞的单细胞 RNA 测序揭示了基因表达特征,表明患者 CD8 T 细胞向促炎、效应样状态转变。此外,患者 CD4 T 细胞表现出明显的增殖缺陷,表面检查点抑制剂表达延迟,提示 T 细胞激活程序的启动受损。总之,我们确定了一种以前未表征的、胚系编码的先天性免疫缺陷,并发现了 Helios 依赖性表观遗传调控的细胞特异性缺陷。Helios 与特定伴侣的结合介导了这种调节,这对于健康和疾病中 T 细胞稳态的转录程序是最终必需的。